Influenza Virus Binding Peptides

Influenza virus binding peptides and methods for using these peptides are disclosed. In an embodiment a peptide having from 8 to 40 amino acids includes a sequence X1-X2-X3-X4-Asp-X5-X6-X7 (SEQ ID NO:2), wherein X1 to X7 are selected from Ala, Asn, Asp, Arg, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, M...

Full description

Saved in:
Bibliographic Details
Main Authors Stöcklein Walter F.M, Bier Frank F, Ehrentreich-Förster Eva, Memczak Henry, Herrmann Andreas, Lauster Daniel
Format Patent
LanguageEnglish
Published 15.03.2018
Subjects
CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:Influenza virus binding peptides and methods for using these peptides are disclosed. In an embodiment a peptide having from 8 to 40 amino acids includes a sequence X1-X2-X3-X4-Asp-X5-X6-X7 (SEQ ID NO:2), wherein X1 to X7 are selected from Ala, Asn, Asp, Arg, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr and Val, and wherein SEQ ID NO:2 has at least 62.5% sequence identity and at most 87.5% sequence identity with the sequence Phe-Tyr-Asp-Tyr-Asp-Val-Phe-Tyr (SEQ ID NO:1).
Bibliography:Application Number: US201515528389